Ikarian Capital, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 143 filers reported holding KRYSTAL BIOTECH INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$9,802,000
+710.6%
845
-91.8%
1.18%
+510.9%
Q2 2023$1,209,220
+46.6%
10,3000.0%0.19%
+3.2%
Q1 2023$824,618
-93.7%
10,300
-93.8%
0.19%
-94.1%
Q4 2022$13,142,598
+98.1%
165,900
+74.3%
3.17%
+139.9%
Q3 2022$6,635,000
-77.9%
95,200
-83.4%
1.32%
-37.4%
Q3 2021$30,012,000574,8002.11%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders